VYGR · Company research
Voyager Therapeutics, Inc. (VYGR): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.46 | $159,846,358.32 | 124077358.32 | 0.82491582491582491582 | — | — | 50.5043786161137441 | 1.03542858275520317146 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.